Kusurinomadoguchi, Inc.
5592
Rank in Stocks
#17762
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan,... Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.
Share Price
$13.14
Last synced: 2026-11-19
Market Cap
$148.02M
Change (1 day)
1.01%
Change (1 year)
-23.77%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Kusurinomadoguchi, Inc. (5592)
Category
Healthcare
Operating Margin for Kusurinomadoguchi, Inc. (5592)
Operating Margin as of November 2026 TTM: 21.34%
According to Kusurinomadoguchi, Inc.'s latest financial reports, its current operating margin (TTM) is 21.34%. At the end of 2025 the company had an operating margin of 17.47%.
Operating Margin history for Kusurinomadoguchi, Inc. from 2022 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 21.34% | 22.15% |
| 2025 | 17.47% | 11.20% |
| 2024 | 15.71% | 11.02% |
| 2023 | 14.15% | 28.40% |
| 2022 | 11.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.33% | -99.38% |
US
|
|
| 3.61% | -99.83% |
US
|
|
| 74.94% | -96.49% |
AU
|
|
| -18.48% | -100.87% |
US
|
|
| 18.74% | -99.12% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Kusurinomadoguchi, Inc.'s operating margin
What is Kusurinomadoguchi, Inc.'s operating margin?
Kusurinomadoguchi, Inc.'s operating margin is 21.34%, as of Nov 2026.
What was Kusurinomadoguchi, Inc.'s operating margin in 2025?
In 2025, Kusurinomadoguchi, Inc.'s operating margin was 17.47%, compared with 15.71% in 2024.
How has Kusurinomadoguchi, Inc.'s operating margin changed since 2022?
From 2022 to 2025, Kusurinomadoguchi, Inc.'s operating margin was highest in 2025 (17.47%) and lowest in 2022 (11.02%).
How does Kusurinomadoguchi, Inc.'s operating margin compare with similar companies?
Kusurinomadoguchi, Inc.'s operating margin (21.34%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Pro Medicus Limited, with 74.94%.